We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$214M
Cap. Flow
+$201M
Cap. Flow %
13.22%
Top 10 Hldgs %
33.88%
Holding
311
New
21
Increased
84
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$24.9M
2
SYK icon
Stryker
SYK
+$24.6M
3
APA icon
APA Corp
APA
+$23.1M
4
NUE icon
Nucor
NUE
+$21.9M
5
CMCSA icon
Comcast
CMCSA
+$18.9M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$32.8M
2
HBI
Hanesbrands
HBI
+$15.1M
3
CHD icon
Church & Dwight Co
CHD
+$9.02M
4
NEE icon
NextEra Energy
NEE
+$9M
5
KO icon
Coca-Cola
KO
+$5.35M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Materials 13.93%
3 Communication Services 13.6%
4 Healthcare 10.39%
5 Energy 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNN icon
201
Lindsay Corp
LNN
$1.12B
$296K 0.02%
4,000
– –
UFPI icon
202
UFP Industries
UFPI
$4.87B
$295K 0.02%
9,000
– –
UPRO icon
203
ProShares UltraPro S&P 500
UPRO
$5.13B
$295K 0.02%
+24,000
New +$292K
TSCO icon
204
Tractor Supply
TSCO
$15.8B
$293K 0.02%
21,775
– –
CSCO icon
205
Cisco
CSCO
$448B
$292K 0.02%
9,199
+1,140
+14% +$35.1K
NOK icon
206
Nokia
NOK
$50.7B
$290K 0.02%
50,000
– –
E icon
207
ENI
E
$80.5B
$289K 0.02%
10,000
– –
HMC icon
208
Honda
HMC
$39.9B
$289K 0.02%
10,000
– –
PNR icon
209
Pentair
PNR
$10.6B
$289K 0.02%
6,701
– –
AXON
210
Axon Enterprise
AXON
$42.3B
$286K 0.02%
10,000
– –
GILD icon
211
Gilead Sciences
GILD
$163B
$286K 0.02%
3,620
-345
-9% -$28K
SCI icon
212
Service Corp International
SCI
$11.8B
$285K 0.02%
10,755
+255
+2% +$6.91K
MAS icon
213
Masco
MAS
$14.2B
$284K 0.02%
8,275
– –
ULTA icon
214
Ulta Beauty
ULTA
$22.2B
$283K 0.02%
+1,191
New +$301K
ALGN icon
215
Align Technology
ALGN
$12.4B
$281K 0.02%
3,000
– –
PWR icon
216
Quanta Services
PWR
$98.7B
$280K 0.02%
10,000
– –
BXP icon
217
Boston Properties
BXP
$11.4B
$279K 0.02%
2,050
-303
-13% -$42K
ITRI icon
218
Itron
ITRI
$4.33B
$279K 0.02%
5,000
– –
PARA
219
DELISTED
Paramount Global Class B
PARA
$278K 0.02%
+5,075
New +$269K
ROP icon
220
Roper Technologies
ROP
$38.5B
$274K 0.02%
1,500
– –
EMN icon
221
Eastman Chemical
EMN
$8.01B
$271K 0.02%
4,000
– –
KMI icon
222
Kinder Morgan
KMI
$70.5B
$271K 0.02%
11,700
– –
HAL icon
223
Halliburton
HAL
$26.4B
$269K 0.02%
6,000
– –
VMI icon
224
Valmont Industries
VMI
$9.2B
$269K 0.02%
2,000
– –
GPRO icon
225
GoPro
GPRO
$124M
$267K 0.02%
16,000
+3,950
+33% +$54.2K
7 8
9
10 11

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q3 2016 Portfolio in Review

As of Q3 2016, R.H. Bluestein & Co held 311 positions worth $1.52B, up 16% from $1.31B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

R.H. Bluestein & Co deployed $201M of net new capital in Q3 2016, opening 21 new positions and adding to 84 existing holdings. Its largest new stake was APA Corp: 423,532 shares worth $27.1M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Boston Scientific, an estimated $32.8M trimmed.

  • R.H. Bluestein & Co's largest Q3 2016 buy was APA Corp: 423,532 shares worth $27.1M.
  • R.H. Bluestein & Co added most to Chubb in Q3 2016, an estimated $24.9M increase.
  • R.H. Bluestein & Co's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $32.8M.
  • R.H. Bluestein & Co fully exited Hanesbrands in Q3 2016, selling an estimated $15.1M.
  • R.H. Bluestein & Co's ten largest holdings make up 34% of its $1.52B portfolio in Q3 2016.
  • R.H. Bluestein & Co opened 21 new positions and closed 15 in Q3 2016.
  • R.H. Bluestein & Co's portfolio value rose 16% quarter-over-quarter to $1.52B.

Based on R.H. Bluestein & Co's 13F filing for Q3 2016, filed 14 Nov 2016.